After years of developing what it hopes will be a Blockbuster drug to treat the hepatitis C virus, vertex pharmaceuticals Inc. of Cambridge is rapidly closing in on its goal: a product that could generate billions of dollars in annual revenue.
Vertex nearing goal on hepatitis C drug.